Low calcium dialysate combined with CaCO(3) in hyperphosphatemia in hemodialysis patients

This aim of this study was to observe the effects of the application of low calcium dialysate (LCD) combined with oral administration of CaCO(3) in the treatment of hyperphosphatemia, as well as blood Ca(2+), calcium-phosphate product (CPP), parathyroid hormone (PTH) and blood pressure in patients u...

Descripción completa

Detalles Bibliográficos
Autores principales: GAO, ZHUO, LUN, LI-DE, LI, XIN-LUN
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2013
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3702715/
https://www.ncbi.nlm.nih.gov/pubmed/23837063
http://dx.doi.org/10.3892/etm.2013.1067

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3702715/
https://www.ncbi.nlm.nih.gov/pubmed/23837063
http://dx.doi.org/10.3892/etm.2013.1067

Ejemplares similares